Evelo Biosciences Inc

NASDAQ:EVLO  
9.48
+0.05 (+0.53%)
Earnings Announcements

Evelo Biosciences Reports Quarterly Loss Per Share $0.62

Published: 03/09/2021 12:50 GMT
Evelo Biosciences Inc (EVLO) - Evelo Biosciences Announces Fourth Quarter and Full Year 2020 Financial Results and Business Highlights.
Evelo Biosciences Inc Quarterly Loss per Share $0.62.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.52

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.53

More details on our Analysts Page.